Achilles Therapeutics PLC (ACHL)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 3.6M | -1.18M | 1.09M | 1.21M | 2.39M | 1.39M | 2M | 1.43M |
Operating Income | -11.76M | -35.12M | -17.46M | -15.7M | -16.09M | -17.53M | -11.58M | -19.38M |
Pre Tax Income | -12.44M | -24.02M | -17.46M | -16.88M | -16.71M | -18.13M | -12.3M | -16.37M |
Net Income | -12.48M | -24.06M | -17.51M | -16.85M | -16.68M | -18.63M | -12.27M | -16.38M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -11.76M | -35.12M | -17.46M | -15.7M | -16.09M | -17.53M | -11.58M | -19.38M |
EBITDA | -10.87M | -37.98M | -17.46M | -13.34M | -14.89M | -16.38M | -10.4M | -20.56M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 531k | 3.13M | 7.32M | 6.08M |
Operating Income | -13.76M | -33.2M | -61.06M | -71.13M | -66.78M |
Pre Tax Income | -13.99M | -33.2M | -61.06M | -71.07M | -69.17M |
Net Income | -13.99M | -33.2M | -61.1M | -71.18M | -69.67M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 |
EBIT | -13.98M | -33.2M | -61.06M | -71.13M | -66.78M |
EBITDA | -13.46M | -32.42M | -61.06M | -59.99M | -62.06M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.